只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-27 2026-07-29 | AVTX Avalo Therapeutics, Inc. | Doyle Mittie Officer · Chief Medical Officer | 卖出（S） | 1,000 | US$20.00 | US$20,000.00 | 51,776 | SEC |
| 2026-07-08 2026-07-09 | SAIL SailPoint, Inc. | Schmitt Christopher Officer · General Counsel and Secretary | 卖出（S） | 18,890 | US$15.42 | US$291,193.13 | 1,312,721 | SEC |
| 2026-07-07 2026-07-09 | SAIL SailPoint, Inc. | Schmitt Christopher Officer · General Counsel and Secretary | 卖出（S） | 15,569 | US$16.05 | US$249,905.80 | 1,339,982 | SEC |
| 2026-07-07 2026-07-09 | SAIL SailPoint, Inc. | Schmitt Christopher Officer · General Counsel and Secretary | 卖出（S） | 8,371 | US$16.73 | US$140,038.46 | 1,331,611 | SEC |
| 2026-07-01 2026-07-06 | META Meta Platforms, Inc. | KIMMITT ROBERT M Director | 卖出（S） | 500 | US$607.75 | US$303,875.00 | 3,443 | SEC |
| 2026-06-30 2026-07-02 | AVTX Avalo Therapeutics, Inc. | Doyle Mittie Officer · Chief Medical Officer | 卖出（S） | 4,654 | US$20.00 | US$93,080.00 | 51,776 | SEC |
| 2026-06-23 2026-06-25 | AVTX Avalo Therapeutics, Inc. | Doyle Mittie Officer · Chief Medical Officer | 卖出（S） | 1,450 | US$18.00 | US$26,100.00 | 51,776 | SEC |
| 2026-06-12 2026-06-15 | SKWD Skyward Specialty Insurance Group, Inc. | Schmitt Thomas N Officer · CPO, Skyward Group | 卖出（S） | 8,397 | US$51.32 | US$430,934.04 | 10,353 | SEC |
| 2026-06-01 2026-06-03 | META Meta Platforms, Inc. | KIMMITT ROBERT M Director | 卖出（S） | 504 | US$629.29 | US$317,162.16 | 3,943 | SEC |
| 2026-05-28 2026-06-01 | AVTX Avalo Therapeutics, Inc. | Doyle Mittie Officer · Chief Medical Officer | 卖出（S） | 679 | US$16.00 | US$10,864.00 | 47,122 | SEC |
| 2026-05-15 2026-05-19 | AVTX Avalo Therapeutics, Inc. | Doyle Mittie Officer · Chief Medical Officer | 卖出（S） | 3,000 | US$18.76 | US$56,280.00 | 3,622 | SEC |
| 2026-05-12 2026-05-13 | WCN Waste Connections, Inc. | MITTELSTAEDT RONALD J Director,Officer · President & CEO | 买入（P） | 50,000 | US$152.24 | US$761.2万 | 301,017 | SEC |
| 2026-05-11 2026-05-13 | PFLEX PIMCO Flexible Credit Income Fund | MITTAL MOHIT Other | 买入（P） | 291,537.91 | US$6.86 | US$200万 | 291,537.91 | SEC |
| 2026-05-06 2026-05-07 | AVTX Avalo Therapeutics, Inc. | Doyle Mittie Officer · Chief Medical Officer | 卖出（S） | 19,015 | US$22.41 | US$426,126.15 | 13,680 | SEC |
| 2026-05-06 2026-05-07 | AVTX Avalo Therapeutics, Inc. | Doyle Mittie Officer · Chief Medical Officer | 卖出（S） | 44,944 | US$21.20 | US$952,812.80 | 32,695 | SEC |
| 2026-05-06 2026-05-07 | AVTX Avalo Therapeutics, Inc. | Doyle Mittie Officer · Chief Medical Officer | 卖出（S） | 5,000 | US$19.65 | US$98,250.00 | 77,639 | SEC |
| 2026-05-06 2026-05-07 | AVTX Avalo Therapeutics, Inc. | Doyle Mittie Officer · Chief Medical Officer | 卖出（S） | 27,538 | US$18.03 | US$496,510.14 | 82,639 | SEC |
| 2026-05-06 2026-05-07 | AVTX Avalo Therapeutics, Inc. | Doyle Mittie Officer · Chief Medical Officer | 卖出（S） | 10,058 | US$22.88 | US$230,127.04 | 3,622 | SEC |
| 2026-05-05 2026-05-07 | AVTX Avalo Therapeutics, Inc. | Doyle Mittie Officer · Chief Medical Officer | 卖出（S） | 1,679 | US$16.00 | US$26,864.00 | 3,622 | SEC |
| 2026-04-15 2026-04-17 | META Meta Platforms, Inc. | KIMMITT ROBERT M Director | 卖出（S） | 580 | US$667.00 | US$386,860.00 | 3,847 | SEC |
| 2026-04-09 2026-04-09 | SAIL SailPoint, Inc. | Schmitt Christopher Officer · General Counsel and Secretary | 卖出（S） | 17,933 | US$11.42 | US$204,794.86 | 1,356,431 | SEC |
| 2026-04-09 2026-04-09 | SAIL SailPoint, Inc. | Schmitt Christopher Officer · General Counsel and Secretary | 卖出（S） | 880 | US$12.21 | US$10,744.80 | 1,355,551 | SEC |
| 2026-04-08 2026-04-09 | SAIL SailPoint, Inc. | Schmitt Christopher Officer · General Counsel and Secretary | 卖出（S） | 13,624 | US$12.80 | US$174,387.20 | 1,374,364 | SEC |
| 2026-04-07 2026-04-09 | SAIL SailPoint, Inc. | Schmitt Christopher Officer · General Counsel and Secretary | 卖出（S） | 13,637 | US$12.72 | US$173,462.64 | 1,387,988 | SEC |
| 2026-04-06 2026-04-08 | AVTX Avalo Therapeutics, Inc. | Doyle Mittie Officer · Chief Medical Officer | 卖出（S） | 3,970 | US$18.01 | US$71,499.70 | 3,622 | SEC |
| 2026-04-01 2026-04-03 | AVTX Avalo Therapeutics, Inc. | Doyle Mittie Officer · Chief Medical Officer | 卖出（S） | 679 | US$16.00 | US$10,864.00 | 3,622 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| MITT | 46,851.1449 | 209 | 78,897.9368 | 59.38% | B, Q, N |
| MITTPA | 500 | 0 | 1,611.0473 | 31.04% | Q, N |
| MITTPB | 273 | 0 | 1,266.1694 | 21.56% | Q |
| MITTPC | 380 | 0 | 6,966.6496 | 5.45% | Q |